首页> 外文期刊>Journal of Chromatography, Biomedical Applications >Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography
【24h】

Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography

机译:手性液相色谱法分析西酞普兰及其脱甲基代谢产物的对映体

获取原文
获取原文并翻译 | 示例
       

摘要

A procedure using a chirobiotic V column is presented which allows separation of the enantiomers of citalopram and its two N-demethylated metabolites, and of the internal standard, alprenolol, in human plasma. Citalopram, demethylcitalopram and didemethylcitalopram, as well as the internal standard, were recovered from plasma by liquid-liquid extraction. The limits of quantification were found to be 5 ng/ml for each enantiomer of citalopram and demethylcitalopram, and 7.5 ng/ml for each enantiomer of didemethylcitalopram. Inter- and intra-day coefficients of variation varied from 2.4% to 8.6% for S- and R-citalopram, from 2.9% to 7.4% for S- and R-demethylcitalopram, and from 5.6% to 12.4% for S- and R-didemethylcitalopram. No interference was observed from endogenous compounds following the extraction of plasma samples from 10 different patients treated with citalopram. This method allows accurate quantification for each enantiomer and is, therefore, well suited for pharmacokinetic and drug interaction investigations. The presented method replaces a previously described highly sensitive and selective high-performance liquid chromatography procedure using an acetylated beta-cyclobond column which, because of manufactural problems, is no longer usable for the separation of the enantiomers of citalopram and its demethylated metabolites. (C) 1998 Elsevier Science B.V. All rights reserved. [References: 10]
机译:提出了使用手性V柱的方法,该方法可以在人血浆中分离西酞普兰及其两个N-去甲基化代谢产物的对映异构体以及内标阿普洛尔。通过液-液萃取从血浆中回收西酞普兰,去甲基西酞普兰和二甲基甲基西酞普兰以及内标。对于西酞普兰和去甲基西酞普兰的每个对映体,定量限为5 ng / ml,对二甲基甲基西酞普兰的每个对映体为7.5 ng / ml。 S-和R-西酞普兰的日间和日内变异系数从2.4%变化到8.6%,S-和R-去甲基西酞普兰从2.9%到7.4%,S-和R从5.6%到12.4% -二甲基甲基西酞普兰。从10名接受西酞普兰治疗的不同患者中提取血浆样品后,未观察到内源性化合物的干扰。该方法可对每种对映异构体进行准确定量,因此非常适合进行药代动力学和药物相互作用研究。所提出的方法代替了先前描述的使用乙酰化β-环键色谱柱的高灵敏度和选择性的高效液相色谱程序,该色谱柱由于制造问题而不再可用于分离西酞普兰及其去甲基化代谢物的对映异构体。 (C)1998 Elsevier Science B.V.保留所有权利。 [参考:10]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号